Clinical trials
Prostatic Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 16 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Active, not recruiting | 28 |
| Recruiting | 24 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 16 |
| Janssen Research & Development, LLC | 7 |
| Novartis Pharmaceuticals | 7 |
| Bayer | 6 |
| Eli Lilly and Company | 6 |
| Merck Sharp & Dohme LLC | 6 |
| Pfizer | 6 |
| Amgen | 5 |
| Astellas Pharma Inc | 5 |
| Sanofi | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 106 |
| Breast Neoplasms | 9 |
| Neoplasm Metastasis | 9 |
| Ovarian Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Endometrial Neoplasms | 5 |
| Esophageal Neoplasms | 5 |
| Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
Trials
Showing 26 to 50 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.